Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-03-31 00:00:00 ET · period of report 2026-03-31 · accession 0001061983-26-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-03-31 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $65.00 | -3,639 | 66.0K | -5% | -$236.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | S | D | 3,639 | $65.00 | 66,004 | D | — | — |